Misadventures to patients during surgical and medical care in England and Wales: an analysis of deaths and hospital episodes.

Department of Nutrition & Public Health Intervention Research, London School of Hygiene & Tropical Medicine, UK.
Journal of the Royal Society of Medicine (Impact Factor: 2.12). 07/2011; 104(7):292-8. DOI: 10.1258/jrsm.2011.100408
Source: PubMed

ABSTRACT Objectives To estimate incidence of injury to patients attributed to misadventures during surgical and medical care by age group and to examine recent trends. Design Analysis of routine morbidity and mortality data categorized by the 9th and 10th revisions of the International Classification of Diseases. Participants Children 0-14 years and adults ≥15 years. Setting England and Wales during 1999 to 2008 (hospital episodes) and 1979 to 2009 (deaths). Main outcome measures We calculated deaths per million person-years and per 1000 hospital episodes; hospital episodes per 100,000 person-years and per 100,000 procedures performed. Results The rate of death attributed to misadventures during surgical and medical care in patients aged 75 years and older was over 50 times (rate ratio 57.2; 95% confidence interval 38.3-85.3) higher than in children aged 1-14 years. Estimated hospital episode rates were 20 times (RR 20.0; 18.9-21.2) higher in patients aged 75 years and older. Mortality attributed to misadventures declined from 1.1 (0.9-1.4) deaths per million person-years in 1979 to 0.4 (0.2-0.6) in 2009. Hospital episodes of misadventures decreased between 1999 and 2008 from 30.8 (29.9-31.8) episodes per 100,000 procedures to 23.25 (22.5-24.1), but increased from 7.8 (7.6-8.1) per 100,000 person-years to 9.8 (9.5-10.1). Conclusions Misadventures during surgical and medical care are an important cause of avoidable injury. Older patients appear to be at higher risk of experiencing and dying from misadventure. Interpretation of recent trends is limited by uncertainties regarding the consistency and coverage of coding.

21 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To examine the feasibility of detecting adverse events through record review in British hospitals and to make preliminary estimates of the incidence and costs of adverse events. Retrospective review of 1014 medical and nursing records. Two acute hospitals in Greater London area. Main outcome measure: Number of adverse events. 110 (10.8%) patients experienced an adverse event, with an overall rate of adverse events of 11.7% when multiple adverse events were included. About half of these events were judged preventable with ordinary standards of care. A third of adverse events led to moderate or greater disability or death. These results suggest that adverse events are a serious source of harm to patients and a large drain on NHS resources. Some are major events; others are frequent, minor events that go unnoticed in routine clinical care but together have massive economic consequences.
    BMJ Clinical Research 04/2001; 322(7285):517-9. DOI:10.1136/bmj.322.7285.517 · 14.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Older patients are less likely to receive guideline-recommended medical therapies during acute myocardial infarction. However, it is unclear whether the lower rates of treatment reflect elderly patients' increased number of comorbid conditions, physician or hospital effects, or true age-associated variation. Furthermore, it is unclear whether age-associated variations in care are similar or vary among treatments. We evaluated 146,718 Medicare patients from the Cooperative Cardiovascular Project aged > or =65 years who were hospitalized between 1994 and 1996 with a confirmed myocardial infarction, to ascertain whether rates of acute reperfusion therapy and use of aspirin (admission, discharge), beta-blockers (admission, discharge), and angiotensin-converting enzyme (ACE) inhibitors varied among patients aged 65 to 69 years, 70 to 74 years, 75 to 79 years, 80 to 84 years, and > or =85 years. We identified patients who were considered eligible for each therapy and who had no treatment contraindications. Associations between age and use of therapy were assessed, adjusting for patient, physician, hospital, and geographic factors. Adjusted treatment rates were higher for patients aged 65 to 69 years than for patients aged > or =85 years for acute reperfusion therapy (54.4% vs. 31.2%, P <0.0001 for trend), beta-blockers (admission: 52.2% vs. 43.8%, P <0.0001 for trend; discharge: 61.8% vs. 55.3%, P <0.0001 for trend), aspirin at admission (73.8% vs. 71.0%, P <0.0001 for trend), and ACE inhibitors (61.6% vs. 57.1%, P = 0.02 for trend); there were no differences in the prescription of aspirin at discharge (76.0% vs. 73.6%, P = 0.05). Elderly patients are less likely to receive guideline-indicated therapies when hospitalized with myocardial infarction. The effects of age were largest for acute reperfusion and smallest for aspirin.
    The American Journal of Medicine 04/2003; 114(4):307-15. DOI:10.1016/S0002-9343(02)01531-0 · 5.00 Impact Factor
  • Source
    BMJ (online) 09/2004; 329(7462):369. DOI:10.1136/bmj.329.7462.369 · 17.45 Impact Factor
Show more


21 Reads
Available from